Blood Cancer Talks

1.     Phase III ASAP trial
2.     Phase III Dauno-Double Trial
3.     Reduced venetoclax exposure
4.    Menin Inhibitors in AML
5.    Imetelstat in MDS: IMerge Phase 2
6.    MOMENTUM: Momelotinib

How I manage anemia related to myelofibrosis and its treatment regimens

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk